Mentani A, Maresca M, Shiriaeva A
Cells. 2025; 14(4).
PMID: 39996750
PMC: 11853414.
DOI: 10.3390/cells14040277.
Su F, Siebart J, Chan C, Wang M, Yao X, Trenkle A
bioRxiv. 2024; .
PMID: 39554121
PMC: 11566043.
DOI: 10.1101/2024.10.29.620946.
Poudel B, Fletcher S, Wilton S, Aung-Htut M
Int J Mol Sci. 2024; 25(11).
PMID: 38891760
PMC: 11171558.
DOI: 10.3390/ijms25115572.
Kulkarni A, Chen T, Sidransky E, Han T
Genes (Basel). 2024; 15(3).
PMID: 38540423
PMC: 10970163.
DOI: 10.3390/genes15030364.
Blay E, Hardyman E, Morovic W
Mol Ther Methods Clin Dev. 2023; 31:101132.
PMID: 37964893
PMC: 10641278.
DOI: 10.1016/j.omtm.2023.101132.
Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis.
Stavre Z, Kim J, Yang Y, Nundel K, Chaugule S, Sato T
Proc Natl Acad Sci U S A. 2023; 120(19):e2218019120.
PMID: 37141171
PMC: 10175794.
DOI: 10.1073/pnas.2218019120.
Intrabiliary infusion of naked DNA vectors targets periportal hepatocytes in mice.
Deplazes S, Schlegel A, Song Z, Allegri G, Rimann N, Scherer T
Mol Ther Methods Clin Dev. 2022; 27:352-367.
PMID: 36381301
PMC: 9630613.
DOI: 10.1016/j.omtm.2022.10.006.
Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review.
Zhang J, Zhang T, Gao J
Nanomaterials (Basel). 2022; 12(19).
PMID: 36234452
PMC: 9565336.
DOI: 10.3390/nano12193323.
AAV-mediated gene therapy: Advancing cardiovascular disease treatment.
Zhang H, Zhan Q, Huang B, Wang Y, Wang X
Front Cardiovasc Med. 2022; 9:952755.
PMID: 36061546
PMC: 9437345.
DOI: 10.3389/fcvm.2022.952755.
AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy.
John A, Xie J, Yang Y, Kim J, Lin C, Ma H
Mol Ther Nucleic Acids. 2022; 29:296-311.
PMID: 35950212
PMC: 9352805.
DOI: 10.1016/j.omtn.2022.07.008.
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
Sabatino D, Bushman F, Chandler R, Crystal R, Davidson B, Dolmetsch R
Mol Ther. 2022; 30(8):2646-2663.
PMID: 35690906
PMC: 9372310.
DOI: 10.1016/j.ymthe.2022.06.004.
Gene therapy - are we ready now?.
Kaczmarek R
Haemophilia. 2022; 28 Suppl 4:35-43.
PMID: 35521736
PMC: 9325484.
DOI: 10.1111/hae.14530.
Cancer gene therapy goes viral: viral vector platforms come of age.
Bezeljak U
Radiol Oncol. 2022; 56(1):1-13.
PMID: 35148469
PMC: 8884858.
DOI: 10.2478/raon-2022-0002.
How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?.
Sainz-Ramos M, Gallego I, Villate-Beitia I, Zarate J, Maldonado I, Puras G
Int J Mol Sci. 2021; 22(14).
PMID: 34299164
PMC: 8304344.
DOI: 10.3390/ijms22147545.
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia.
Monahan P, Negrier C, Tarantino M, Valentino L, Mingozzi F
J Clin Med. 2021; 10(11).
PMID: 34199563
PMC: 8199697.
DOI: 10.3390/jcm10112471.
